Humana Inc. has already cut back on sales of individual major medical insurance market, and now it says it’s facing challenges in the private Medicare plan market.
The Louisville, Kentucky-based health insurer talked about the Medicare plan worries today when it announced its earnings for the fourth quarter of 2016.
Humana is reporting a $401 million net loss for the quarter on $13 billion in revenue, compared with $101 million in net income on $13 billion in revenue for the fourth quarter of 2015.
The net loss included two major unusual items: a $583 million write-off of receivables from a troubled Affordable Care Act program, and the addition of $505 million to the reserves for an old block of long-term care insurance business.
Excluding the effects of those charges and some other one-time charges, adjusted operating income for the quarter increased to $643 million, from $452 million for the fourth quarter of 2015.
The company ended the quarter providing or administering health coverage for a total of 14 million people, about as many people as it was covering at the end of 2015.
Medicare worries
The Centers for Medicare & Medicaid Services gave insurers an early look at how the Medicare Advantage and Medicare Part D prescription drug plans might work last week, in the 2018 Medicare program Advance Notice.
Related: CMS seeks bids for Trump’s first Medicare plan menu
Medicare Advantage program managers give plans quality ratings based on a 5-star rating system. Managers are trying to shift toward paying bonuses, or extra subsidy money, to plans with higher Star ratings, and less to plans with lower Star ratings.
Humana is a major Medicare Advantage plan provider. About 3.2 million of the company’s enrollees are in Medicare Advantage plans, down from 3.3 million a year ago.
Humana said that, if the rules in the Advance Notice stick, the quality incentive program might affect how much CMS pays Humana for 2018 Medicare Advantage plan enrollees, because the percentage of Humana enrollees in program plans with ratings of 4 stars or higher has dropped.
“The company continues to believe that its Star ratings for the 2018 bonus year do not accurately reflect the company’s actual performance under certain Star measures,” Humana said in a statement accompanying its earnings release. “The company filed for reconsideration of those measures.”
Humana said that also it might change its “contract structures” to compensate for the effects of Star bonus revenue problems in 2018. Humana did not specify whether it was referring to provider contracts or other types of contracts.
Medicare Advantage is the successor to the old Medicare+Choice managed Medicare plan program. In the late 1990s, Republicans generally supported the idea of encouraging private carriers to sell private Medicare plan alternative coverage. Some Democrats thought the subsidies for the private Medicare plan issuers were too high. Congress capped private Medicare enrollee subsidies. In 2000, the subsidy caps led to Medicare plan issuer turmoil, and many issuer exits from the market.
Related: Inside Products: This side of Medicare HMO withdrawals stinks
Humana also talked today about its participation in the Affordable Care Act public exchange market and the off-exchange individual major medical market.
Humana is reporting a $401 million net loss for the quarter on $13 billion in revenue, compared with $101 million in net income on $13 billion in revenue for the fourth quarter of 2015. (Photo: iStock)
Individual health
Humana said it ended 2016 with 655,000 individual major medical enrollees, down from 899,000 at the end of 2015.
The company said it now has only about 244,000 individual major medical enrollees in 11 states, down from about 655,000 enrollees in 15 states a year earlier.